Lazcluze
Lazertinib · Janssen Biotech, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Lazcluze ingredients
| Active ingredient | Strength |
|---|---|
| Lazertinib | 240 mg/1, 80 mg/1 |
What Lazcluze is used for
Lazcluze is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Lazcluze
- Generic name
- Lazertinib
- Made by
- Janssen Biotech, Inc.
- Forms
- Tablet, Film Coated
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA219008
- On the US market since
- 2024
Official information
- Lazcluze prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Lazertinib)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Lazcluze?
Lazcluze (Lazertinib) is a cancer medicine made by Janssen Biotech, Inc., approved by the US FDA.
What are the ingredients of Lazcluze?
Lazcluze contains Lazertinib (240 mg/1, 80 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA